Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 7
160
Views
7
CrossRef citations to date
0
Altmetric
Short Communications

Linderolide U, a new sesquiterpene from Lindera aggregata root

, &
Pages 1914-1918 | Received 05 Jul 2020, Accepted 25 Aug 2020, Published online: 14 Sep 2020
 

Abstract

A new sesquiterpene, namely linderolide U (1), was isolated from the root of Lindera aggregata (Sims) Kosterm along with five known sesquiterpenes (26). The structures of the obtained compounds were identified by spectroscopic methods, specifically nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). The acquired data were compared with those previously reported in the literature. The anticancer effects of the isolated natural products were studied using the HCT116 human colon cancer cell line. Compound 5 was found to significantly suppress cell proliferation, which was associated with induction of apoptosis and cell cycle arrest (G2/M and S phase). The findings of the present study suggest derivative 5 as a potential agent for the treatment of colon cancer.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The present study was supported by the Grant KSN2013230 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Science, ICT, Republic of Korea.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.